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1. Introduction 
Bacteriophage fd is one of a group of closely-related 
filamentous male-specific coliphages (others are M 13 
and fl). The virion consists of a closed single-stranded 
loop of DNA, 6408 nucleotides in length [1], within 
a tubular array of 2700 subunits of coat protein [2]. 
At one end of the viral filament are ~5 copies of a 
second protein, the adsorption protein or A-protein 
[3 ]; there are also a few copies of 2 or 3 other, smaller 
proteins [4,5 ]. Much is known about the life cycle of 
the virus (review [6]). 
The A-protein is required for adsorption of the 
phage to the host receptor, which is probably the tip 
of the F-pilus [7]. Treatment of the phage with the 
proteinase subtilisin results in digestion of the A-pro- 
tein but not the coat protein, leaving a particle which 
is stable but not infectious [7,8]. Electron microscopy 
reveals that such a particle has lost several small knob- 
like structures located at one end of the native virion 
[9]. The amino acid sequence of the A-protein has 
been deduced by alignment of the N-terminal residues 
of the protein [3] with the translated DNA sequence 
of the phage [1,10]. Further analysis of the structure 
of the A-protein, and its role in adsorption to the 
host cell, has been hindered by its low abundance 
(~1% of the virus (w/w)) and its extreme insolubility; 
isolation of the protein requires complete denaturation 
of the virus with detergent [3,4]. 
Here, we show that mild digestion of phage fd with 
subtilisin releases a large, soluble N-terminal fragment 
of the A-protein. The fragment appears to compete 
with intact phage for attachment sites on the host 
cell. These results uggest models for the structure of 
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the A-protein and its assembly into the virion at the 
host cell membrane. 
2. Materials and methods 
2.1. Materials 
Subtilisin was from Sigma Chemical Co; [methyl- 
3H] acetimidate was synthesized as in [ 11 ]. 
2.2. Growth, purification and radiolabelling of phage 
A sample of phage fd was kindly provided by Dr I. 
Molineux (Imperial Cancer Research Fund, London). 
The phage was grown on Escherichia coli 5274 (from 
the collection of J. Lederberg and provided by Dr J. 
Hewitt, University of Cambridge) and purified by 
polyethylene glycol precipitation and CsC1 density 
centrifugation [12]. 
Purified phage was radiolabelled by treatment with 
0.1 M [methyl-all] acetimidate (13 Ci/mol) in 0.1 M 
sodium borate (pH 10.C) for 15 min at 0°C [11]. 
Under these conditions, only Lyss of the major coat 
protein is amidinated (J. A., R. N. P., unpublished), 
although we know that minor coat proteins are modi- 
fied too [ 11 ]. The modified phage were indistinguish- 
able from native phage by the criteria of adsorption 
spectroscopy, SDS-polyacrylamide g l electropho- 
resis [13] and infectivity (plaque assay) and were 
stored at 4°C in 50 mM Tris-HC1 buffer (pH 7.5) 
containing 1mM EDTA. 
2.3. Preparation and purification of  the A-protein 
fragment 
Phage fd (80 mg in 16 ml), in 5 g/1 NH4HCO3, was 
treated with 80/lg subtilisin (1 mg/ml in 1 mM HC1) 
for 30 min at 37°C. The proteinase was inhibited by 
adding 40/A phenylmethylsulphonyl fluoride (PMSF) 
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(26 mg/ml in ethanol), and most of the phage particles 
were removed by centrifugation (45 000 rev./min 
Beckman SW50-1 rotor, 3 h). The supernatant was 
lyophilised and resuspended in 1 ml 50 mM Tris-HC1, 
1 mM EDTA, 52 rag/1 PMSF (pH 7.5) then applied to 
a column of Sephadex G-50 superfine (50 cm X 
0.3 cm z) equilibrated with the same buffer. Fractions 
(1 hal) were analysed for absorbance at 280 nm and 
by SDS-polyacrylamide g l electrophoresis. Fractions 
containing the A-protein fragment were pooled, 
lyophilised and dissolved in 0.1 ml glass-distilled water. 
As a control, 4 mg phage fd was treated with sub- 
tilisin to which PMSF had already been added. The 
sample was centrifuged, the supernatant was lyoph- 
ilized as before and then dissolved in 100/al distilled 
water. The phage-binding experiment was repeated, 
but with 1/10th (10/al) of the control yophilisate 
replacing the A-protein fragment. The validity of tile 
assay as a measurement of competition was checked 
by investigating the effect of 5-fold and 100-fold 
excesses of unlabelled phage on binding of [3H]- 
amidinated phage. 
2.4. Analysis of the A-protein fragment 
The protein (~0.07 rag) was dissolved in 0.1 M 
sodium hydrogen carbonate containing l 0% propan- 
1-ol and treated with 25 mg diisothiocyanato-amino- 
propyl porous glass beads pore size 75 A (DITC-glass) 
for 16 h at room temperature. The immobilised pro- 
tein was degraded by the Edman procedure in a com- 
puter-controlled solid phase microsequencer of design 
and construction to be described elsewhere (J. E. W., 
in preparation). Phenylthiohydantoins were identified 
by reverse phase chromatography on Zorbax ODS [14]. 
2.5. Biological activity of the A-protein fragment 
The adsorption activity of the fragment was investi- 
gated by diluting the stock solution with distilled 
water (1 : 19, by vol.) and testing its ability to compete 
with radiolabelled intact phage for binding sites on 
the host bacterium. Tubes containing 5 ml nutrient 
broth (5 g/1 yeast extract, 10 g/1 bactotryptone, 5 g/1 
NaC1) were inoculated with 50/11 of an overnight cul- 
ture ofE. coli 5274 and incubated for 6 h at 37°C 
with shaking, to an A s9s of 0.8. The following were 
then added to pairs of tubes: 
(1) [3H]Amidinated bacteriophage fd (3.6 ug in 
10/al) representing ~40 phage particles/bacterial 
cell; 
(2) [3H]Amidinated bacteriophage fd (3.6/ag), 2 ;tl 
diluted A-protein fragment; 
(3) [3H]Amidinated bacteriophage fd (3.6/ag), 20/A 
diluted A-protein fragment; 
(4) [3H]Amidinated bacteriophage fd (3.6/ag), pre- 
digested with subtilisin as for unlabelled phage. 
The tubes were incubated for 20 rain at 37°C, and 
the bacteria were then collected by centrifugation. 
The pellets were dissolved in 3 ml 1% SDS and the 
tubes heated to 100°C for 5 rain. Six portions of 0.3 
ml were taken from each tube for scintillation count- 
ing [111. 
3. Results 
3.1. Purification and app. M r of the A-protein 
fragm en t 
Subtilisin digestion of phage fd caused the disap- 
pearance of A-protein and the corresponding appear- 
ance of a more mobile band on SDS-polyacrylamide 
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Fig.1. Characterization f the A-protein fragment by SDS- 
polyacrylamide g l electrophoresis. (a) Phage fd (0.25 mg) 
was treated with subtilisin (0.25 ~g) for 30 rain at 37°C and 
the phage particles were then removed by centrifugation. The 
supernatant was freeze-dried and analysed by SDS gel electro- 
phoresis [ 13 ]. (b) A control sample (80 ~zg) of untreated phage 
fd. (c) A mixture of marker proteins, with assumed Mr-values 
in brackets, as follows: (1) bovine serum albumin (66 000); 
(2) egg albumin (45 000); (3) trypsinogen, PMSF-treated 
(24 000); (4) lactoglobulin (18 400); (5) lysozyme (14 300); 
(A) A-protein; (A') A-protein fragment; (B) major coat protein. 
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Fig.2. Purification of A-protein fragment by gel filtration. Phage fd (80 rag) was treated with subtilisin (80 ug) for 30 min at 37°C. 
Phage particles were removed by centrifugation and the supernatant was applied to a column of Sephadex G-50 superfine. Frac- 
tions (1 ml) were collected and tubes 5-7 were pooled and freeze-dried: (o)A 28o; Vo, Vt, excluded and total volumes of the 
column, respectively. SDS-polyacrylamide gelelectrophoresis patterns of fractions 7 and 17 are shown inset. 
gel electrophoresis. This component, a putative 
A-protein fragment, remained in the supernatant after 
the bulk of  the phage particles had been pelleted by 
ultracentrifugation, and migrated with app. M r 37 600 
(fig.l). It eluted at the excluded volume during gel 
filtration on Sephadex G-50, whereas residual coat 
protein was retarded by the column and eluted at 
the total volume (fig.2). The fragment was recovered 
in ~15% yield as estimated by amino acid analysis, 
assumingM r 37 600. 
3.2. N-Terminal sequence analysis of the A-protein 
fragment 
Edman degradation of the purified fragment 
revealed the sequence A la -G lu -Thr -Va l -G lu -  
Ser -X-Leu.  This is the N-terminal sequence of the 
intact A-protein as determined by dansyl-Edman 
degradation [3] and translation of the phage DNA 
sequence [10], the latter identifying X as cysteine. 
Thus the fragment represents an N-terminal portion 
of the A-protein. 
3.3. Biological activity of the fragment 
The effect of the fragment on the attachment of 
[3H] amidinated phage fd to host cells is summarised 
in table 1. Addition of the fragment led to a reduc- 
tion in radiolabel bound by the cells; under these con- 
ditions, portions of 2/~1 and 20/al of the diluted frag- 
ment solution caused a decrease in phage binding to 
84% and 27%, respectively, of the binding observed 
with [3H]-labelled phage alone. The value of 27% is 
similar to that found with subtilisin-digested 3H- 
labelled phage (29%, table 1), suggesting that it repre- 
sents non-specific trapping of phage in the bacterial 
pellet. 
In contrast, the control yophilisate, prepared after 
169 
Volume 135, number 1 FEBS LETTERS 
Table 1 
Binding of A-protein fragment and 3H-labelled phage fd to Eseherichia eoli 
Expt. Additions to 5 ml Radioactivity (dpm) bound Percentage of
bacterial culture to bacterial cells value found for 
after centrifugation 3H-labelled 
(duplicate xperiments) phage alone 
A. 1 [3H]Phage (3.6 pg) 3180 100 3620 
2 [3H]Phage (3.6 pg) 2690 84 A-protein fragment (2 pl) 3010 
3 [3H]Phage (3.6 ~zg) 1090 27 A-protein fragment (20 pl) 750 
4 Subtilisin-treated 1140 
29 [3H]phage (3.6 pg) 860 
B. 1 [3H]Phage (3.6 pg) 2720 
100 3360 
[3H]Phage (3.6 pg) 2300 
93 Control yophilysate (10 pl) 3340 
[SH]Phage (3.6 Pg) 1380 
Unmodified phage (18 pg) 1380 
[3H]Phage (3.6 ug) 780 
Unmodified phage (360 pg) 980 
45 
29 
November 1981 
treating phage with subtilisin that had already been 
inhibited by PMSF, had no significant effect on phage 
adsorption (table 1). Thus the observed inhibition of 
phage adsorption by the preparation of A-protein 
fragment is probably caused by the fragment itself, 
rather than by PMSF, subtilisin or any other possible 
contaminants in the preparation. 
The effects of 5- and 100-fold excesses ofunlabelled 
phage on phage binding (table 1) confirm that the 
assay measured competition for binding sites on the 
bacteria. These amounts constitute ~200 and 4000 
unlabelled phage particles/cell, respectively. As each 
bacterium has only a few F-pill [22], the adsorption 
sites should therefore be saturated under these condi- 
tions. Again, ~29% of the total radioactivity incor- 
porated appears to represent non-specific association 
of  phage protein with the bacterial pellet. Thus a 
5-fold excess of  unlabelled phage should reduce the 
incorporation of labelled phage to 41% of the original 
value, in reasonable agreement with the observed 
value of 45%. 
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4. Discussion 
From these experiments, we conclude that sub- 
tilisin digestion of phage fd releases a large, soluble, 
N-terminal domain of the A-protein which appears 
to contain, at least in part, the site for attachment of 
the phage to the host cell. 
This susceptibility of the A-protein to proteolysis 
suggests that the protein is folded into an N-terminal 
domain which is attached to the end of the phage 
filament by an exposed portion of peptide chain. 
In [9], knobbed structures at the end of the phage 
were observed by electron microscopy which were 
removed by subtilisin treatment; a soluble fragment 
of polypeptide chain was recovered, presumably 
derived from the A-protein, with app. M r similar to 
that described here. Thus the knobbed structure is 
likely to be the N-terminal domain of the A-protein, 
leaving the C-terminal region responsible for attach- 
ment of the protein to the end of the viral filament. 
This region contains th~ only long sequence of hydro. 
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phobic amino acids in the protein, a run of 23 
uncharged residues terminating 5 residues from the 
C-terminus [1,10]. It therefore might be suitable for 
binding to the viral coat protein, which is predomi- 
nantly hydrophobic [ 15,16]. The fragment, prepared 
as in [9], has also been found to inhibit infection of 
cells by phage (W. Folkhard, personal communication). 
The specific binding activity, probably to the tip of 
the F-pilus, is therefore likely to be the first step in 
the process of viral infection. 
There are thought o be ~5 copies of the A-protein 
at one end of the viral filament [3], but it is not 
known whether this implies a need for multiple bind- 
ing of  the A-protein to the pilus during infection. 
From the results in table 1, it appears that the A-pro- 
tein fragment retains ~20% of the binding activityof 
intact A-protein in the native phage. This estimate 
could be influenced by damage to the fragment during 
isolation, and its interpretation would depend on the 
number of fragments required to block phage adsorp- 
tion and their mechanism of interaction with the pilus. 
Retraction of the F-pilus is thought o be the mecha- 
nism by which the phage reaches the bacterial mem- 
brane [7,17]. Thus the isolated A-protein fragment 
should provide a convenient probe of the processes of 
phage attachment and entry into the host cell and for 
studies of A-protein interaction with purified pill in vitro 
By comparison of the N-terminal amino acid 
sequence of the A-protein [3] with its gene sequence 
[ 1,10], it appears that the protein is initially synthe- 
sized with a 'leader' peptide similar to that found 
with the phage coat protein [18]. The coat protein 
is known to enter and span the bacterial inner mem- 
brane, with its N-terminus on the outside of the cell, 
before assembly into the phage filament [19]. Thus 
it is likely that the A-protein also enters the mem- 
brane and becomes oriented with its N-terminal 
domain on the 9utside, anchored in the lipid bilayer 
by the C-terminal region. In addition to its role in 
adsorbing the infecting virus to the cell [6-8],  the 
A-protein has been found to play a part in the late 
steps of viral morphogenesis [20], perhaps in helping 
to terminate the assembly correctly when the viral 
DNA has been packaged [21 ]. The end of the filament 
carrying the A-protein, which would logically be the 
first part of the virus to enter the bacterial cell, is 
therefore likely to be the last part of the newly syn- 
thesized virus particle to emerge from the infected 
cell. A model that accommodates all these results is 
shown schematically in fig.3. 
\ 
\ 
Fig.3. A schematic model for completion of assembly of bac- 
teriophage fd. It is proposed that the A-protein is added to 
the last end of the phage particle to emerge through the bac- 
terial cell membranes. Possible participation of another minor 
coat protein at this end of the filament [5] is not shown. The 
drawing is not to scale: (A) A-protein; (B) major coat protein; 
(M) E. coli inner cell membrane; (N) N-terminus; (C) C-ter- 
minus. 
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